Higher-intensity care setting may not be associated with early survival in acute heart failure patients
Early survival in lower-risk patients with acute heart failure may not be related to the intensity of their care setting after ED presentation, according to a recent study. ... Overall, our findings indicated potential opportunity for improvement in the
Some transitional care interventions more effective than others for reducing readmissions and mortality after hospitalizations for heart failure
Studies included adults recruited during or within 1 week of an index hospitalization for heart failure. ... Our findings provide guidance to quality improvement efforts aimed at reducing readmission and mortality rates for persons with HF [heart failure]
New and revised recommendations on the treatment of heart failure were released last week jointly by the American College of Cardiology Foundation and American Heart Association. ... Changes were made in recommendations on heart failure with preserved
Hospitals vary widely in their use of the intensive care unit (ICU) for heart failure patients, a new study found. ... Researchers analyzed more than 160,000 heart failure (HF) discharges from 341 hospitals in 2009 and 2010.
Beta-blockers in heart failure patients with preserved ejection fraction may lower all-cause mortality
There were 19,083 patients with HFPEF (heart failure and an ejection fraction of at least 40%). ... or heart failure hospitalization (HR, 0.89; 95% CI, 0.84 to 0.95; P=0.001).
Adverse event rates for heart attack and heart failure patients declined from 2005-2011, but didn't decline for pneumonia patients or those recovering from surgery, a new analysis found. ... The 61,523 patients in the analysis were hospitalized for acute
Risk stratification using an electronic medical record (EMR) helped reduce readmissions for heart failure, a new study found. ... period. The mean age in both the heart failure group and the control group was 58 years.
They stratified patients by both ejection fraction (reduced, preserved, and not classifiable) and heart failure severity. ... Of these, 5,839 were hospitalized at the health system for heart failure during the study period.
ARBs may offer same efficacy, better tolerability than ACE inhibitors in patients without heart failure
2000. Angiotensin-receptor blockers (ARBs) may be as efficacious and safe as angiotensin-converting enzyme (ACE) inhibitors in patients without heart failure, with the added advantage of better tolerability, a ... Outcomes were all-cause mortality,
Rivaroxaban is a safe, effective choice for patients with heart failure (HF), according to a new study. ... The study results were published early online on May 30 by Circulation: Heart Failure.